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Abstract
Background: HIV-1 transmission rates have been reduced over the last decade, an estimated 2 million
new infections per year arise, including 220,000 paediatric cases. The main post-natal HIV exposure is
through breastfeeding, where both its duration and modality (exclusive or not) are associated with
postnatal transmission. The ANRS 12174 trial compared HIV-1 postnatal transmission of 2 prophylaxis drugs
for infants during lactation (lamivudine and lopinavir-ritonavir). Our objective has been to examine the
feeding practices and the determinants of exclusive/ predominant (EPBF) or any breastfeeding among the
participants of this trial in Burkina Faso, South Africa, Uganda and Zambia.
Methods: Mothers infected with HIV-1 and their uninfected offspring were followed from day 7 after
birth for 50 weeks, keeping monthly records of their feeding patterns. Feeding was classified into 3
categories: 1) exclusive breastfeeding during the first six months, only breast-milk being given to infant
for 6 months, 2) predominant breastfeeding, breast-milk with liquid-based items being given, and 3)
mixed feeding, other non-breast milk or solid food being given in addition to breast milk with or without
liquid-based items. The categories were merged into 2 groups: EPBF applying to infants aged <6 months
and mixed feeding applying to infants of any age. The feeding patterns have been given as Kaplan-Meier
curves. A flexible parametric multiple regression model was used to identify the determinants of the
mothers’ feeding behaviour.
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Results: A total of 1,225 mother-infant pairs provided feeding data from Burkina Faso (N = 204), South
Africa (N = 213), Uganda (N = 274) and Zambia (N = 534) between November 2009 and March 2013. The
mean maternal age was 27.4 years and the mean BMI was 24.5. 57.7 and 93.9% of mothers initiated
breastfeeding within the first hour and first day, respectively. Overall, the median durations of any form of
breastfeeding and EPBF were 40.6, and 20.9 weeks, respectively. Babies randomized to the lopinavir/
ritonavir group in South Africa tended to do less EPBF than those in the lamivudine group.
Overall the group of mothers aged between 25 and 30 years, those married, employed or multiparous
tended to stop early EPBF. Mothers living in Uganda or Zambia, those aged between 25 -30 years, better
educated (at least secondary school level), employed or having undergone C-section stopped any
breastfeeding early.
Conclusions: There is a need to improve breastfeeding and complementary feeding practices of children, particularly
those exposed to HIV and anti-retrovirals, taking into account context and socio-demographic factors.
Trial registration: Clinical trial registration: NCT00640263.
Keywords: HIV infection, Exclusive breastfeeding, Vertical transmission, Prevention, Sub Saharan Africa, Risk factors,
Cohort study
Background
Worldwide, there are 2.6 million children <15 years
old living with the Human Immuno-deficiency Virus
(HIV). Mother-to-child transmission of HIV-1
(MTCT) through pregnancy, childbirth and breast-
feeding are the main routes of transmission accord-
ing to estimates made in 2015 through the United
Nations programme on HIV/AIDS (UNAIDS) [1].
Even if transmission rates have been reduced over
the last decade, an estimated 2 million new HIV-1
infections occur per year including 220,000 paediat-
ric cases [1]. Improved prevention of mother-to-child
transmission of HIV-1 (PMTCT) strategies and
programme implementation strengthening are there-
fore needed. Postnatal HIV-1 exposure can be
avoided by replacement feeding, but this has been
detrimental in settings with a high child mortality
[2–4]. Non-breastfed children will also be deprived
of the many known benefits of breastfeeding - better
survival rates, and immunological and nutritional
status [5–9]. Developmental [10] benefits include
bonding of the mother-infant dyad, natural spacing
of pregnancies [11] and cultural acceptability [12].
Mixed feeding seems to be the most risky option
during the first 6 months of life regarding HIV
transmission for infants born to mothers living with
HIV-1 where there is no antiretroviral therapy (ART)
[13–15]. Reasons for mixed feeding include social,
cultural, tradition and individual factors of the
mother [16–19]. Breastfeeding is traditional in Sub-
Saharan Africa, but exclusive breastfeeding (EBF) is
not [16, 19–24]. The prevalence of EBF ranges from
22 to 37% in this region, whereas it is estimated glo-
bally to be 35% [25, 26]. Factors known to negatively
influence the practice of EBF are a) late initiation of
breastfeeding (after one h postnatally), b) not giving
colostrum, and c) provision of pre-lacteal feeds [25, 27, 28].
By giving ART to pregnant or breastfeeding women, post-
natal HIV-transmission can be substantially reduced [29].
For these reasons, the World Health Organization
(WHO) currently recommends HIV-infected pregnant
women to breastfeed when formula is unsafe, i.e. as in
most of Sub-Saharan Africa. At the time of the trial, ex-
clusive breastfeeding for 6 months was recommended
and thereafter, to introduce complementary food while
continuing breastfeeding up to a year or until safe re-
placement feeding could be provided [30]. Potential
strategies included the infant’s protection during the
breastfeeding period, either by ART to the mother (op-
tion B or B+) or peri-exposure prophylaxis to the child
(option A) [29–31]. However, maternal ART does not
entirely eliminate postnatal MTCT, probably because of
the persistence of a residual stable CD4+ T cell-
associated reservoir of HIV-1 in breast milk [32]. Thus
prolonged infant prophylaxis covering the entire rec-
ommended breastfeeding period was tested in the
ANRS 12174 trial [33]. The trial aimed to compare the
efficacy of lopinavir/ritonavir versus lamivudine to pre-
vent the mother to child transmission of HIV-1 during
breastfeeding period. The postnatal transmission rates
were 1.4% (95% confidence interval [CI]; 0.4;2.5) and 1.5%
(CI 0.7;2.5), respectively, in the lopinavir/ritonavir and
lamivudine arms [34]. However, as breastfeeding is the
main post-natal HIV exposure, and because its duration
and modality (exclusive or not) are associated with post-
natal transmission, we examined feeding practices and the
determinants of exclusive and predominant breastfeeding
practices of all participants in this trial.
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Methods
Study design
The ANRS 12174 clinical trial in Ouagadougou (Burkina
Faso), East London (South Africa), Mbale (Uganda) and
Lusaka (Zambia) was conducted from 2009 to 2013. The
protocol and the main outcome have been published
[33, 34]. Briefly, HIV-1 infected pregnant women at the
time ineligible for highly active antiretroviral therapy
(HAART) because their CD4 count was >350 cells/
mm3, aged 18 or above, planning to breastfeed and with
between 28 and 40 weeks of amenorrhea, were identified
from antenatal clinics. They received a pre-test counsel-
ling session before being tested for HIV infection. As
part of the post-test session, they were informed of the
different feeding options available for their babies. Only
women wanting to breastfeed were referred to the re-
search clinic for further assessment of the inclusion cri-
teria during the antenatal period, and again with their
child within 6 days after birth, for an enrolment and
site-stratified randomisation at day 7 postpartum. From
28 weeks of pregnancy to day 7 after birth, program-
matic mother to child transmission prophylaxis was im-
plemented according to national guidelines, but mainly
with antenatal zidovudine, an intrapartum single dose
nevirapine and zidovudine-lamivudine for mothers and
nevirapine for infants for 7 days postpartum. We ex-
cluded twins and triplets, infants positive in the HIV-1
DNA PCR test result at day 7 (±2 days) postpartum, low
birth-weight or ill babies (ranked grade II or above of
the DAIDS classification for adverse events) on the day
of enrolment [35].
The intervention was infant prophylaxis in the breast-
feeding period plus one week from day 7 to 50 weeks of
age with either lopinavir/ritonavir or lamivudine. Lami-
vudine is generally well tolerated and accepted; it has
been widely used in research and programs. Lopinavir/
ritonavir paediatric formulation has been a promising
prophylactic drug with low risks for resistance, high
antiviral potency and a good safety profile [33]. However,
it has poor palatability, which mattered less when intro-
duced very early. Breastfeeding recalls of 24-h and one
week were collected during the enrolment visit at day 7
± 2 days after birth, and the 13 monthly scheduled
follow-up visits starting at week 2. Prelacteal feeding
data (which we defined as any food items except
mothers’ milk given to infants before mothers initiated
breastfeeding) were also collected at enrolment.
Data management and analysis
Data were collected on case report forms or directly en-
tered online using the Electronic Data capture system,
viz. OpenClinica® (https://www.openclinica.com). Based
on the data collected at each visit, we categorized
mothers into one of the following groups: 1) exclusive
breastfeeding (EBF - only breast milk being given to the
infant without any other kind of food or liquid except
medically prescribed drugs or vitamins); 2) predominant
breastfeeding (PBF - breast milk with some liquid-based
food such as juice, tea, sugar-water and salt-water, includ-
ing glucose without any kind of formula or animal milk);
and 3) mixed feeding (MF - breast milk with other solid
or other kind of milks with or without liquid-based food).
We thereafter combined EBF and PBF into one group
called “exclusive and predominant breastfeeding” (EPBF)
as PBF presented few cases and was assessed to present
the same risk than EBF at least with regard to postnatal
HIV transmission [15]. The entire cohort was in this EPBF
group at the beginning of the study and were followed up
to detect any change to mixed feeding or non-
breastfeeding by week 26 post-partum, the time when it is
recommended to change from exclusive breastfeeding to
complementary feeding. Any breastfeeding was defined as
women breastfeeding whatever the pattern (exclusive, pre-
dominant or mixed feeding). Any breastfeeding applied
during the whole duration of the study from day 7 to week
50 and was opposed to non-breastfeeding. We have also
included women who stopped breastfeeding and eventu-
ally resumed it. We determined the number and mean
duration of the periods with resumed breastfeeding be-
tween day 7 and week 50 postpartum.
For continuous variables, the median with inter-
quartile range (IQR) were reported, and percentages for
categorical variables. Comparison across categorical vari-
ables was done using the Chi-squared test. We described
the participants’ feeding patterns using Kaplan-Meier
survival curves for each country. The censoring date was
the date of the child’s death, discontinuation, the last
EPBF date or 22 weeks for those who completed the
study without reporting any mixed feeding. The exit date
for survival analysis was set at week 22, since prior to
this time-point any stopping of EPBF was assumed to be
participant-driven whereas at week 26 or later, it was
induced by the trial requirements.
We also explored potentially modulating factors asso-
ciated with early cessation of EPBF, as well as the early
weaning before 50 weeks in a non-proportional hazard
flexible parametric multiple regression analysis with dur-
ation of EPBF, or any breastfeeding as continuous vari-
ables using the “stpm2” command in Stata [36, 37].
Variables with a p ≤ 0.20 in the bivariate analysis were
considered for the multivariate analysis in the pooled-
data analysis of all the countries. Other covariates
included the trial arm, trial country and the maternal
age in 3 age groups (<25 years, 25 to 30 and 30+). The
rest of the covariates were used as dichotomised vari-
ables (single vs. married or co-habiting, primi- vs. mul-
tipara, vaginal vs. caesarean section delivery, primary vs.
secondary school or higher, breastfeeding initiation in
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time within the first hour postpartum vs. later. We also
presented a country-specific analysis catering for con-
textual variation in factors associated with the feeding
behaviour of the neonates. Since South Africa has a dif-
ferent socio-economic and cultural context, we stratified
the data by creating 2 models - South Africa alone, and
Uganda and Zambia together. Burkina Faso was ex-
cluded from these analyses due to the very small num-
bers of observations (women initiating mixed feeding in
the study period before week 26). The same list of vari-
ables was used in the country-specific analysis regardless
of the p-value in the bivariate analysis. Statistical analysis
was done using STATA/SE 13.1 (4905 Lakeway Drive
College Station, Texas 77845 USA).
Ethics consent and permissions
Prior to enrolment, the mothers signed a written in-
formed consent and assent form for themselves and
their children, respectively. The trial was conducted ac-
cording to the sponsor (ANRS) ethic charter, Good Clin-
ical Practices and the principles of the Helsinki
declaration. The protocol was approved by the relevant
ethics committees in the four participating countries and
the Medicines Control Council in South Africa.
Results
Baseline characteristics and feeding patterns
In the ANRS 12174 trial, 1,273 mother-infant pairs were
randomized, of which 6 were excluded due to protocol
violation. Of the remaining 1,267 participants, 204 were
from Ouagadougou, 222 from East London, 278 from
Mbale and 563 from Lusaka. Another 42 were excluded
from analysis due to lack of breastfeeding data after in-
clusion (Fig. 1). Trial profile.
The mothers excluded from analysis tended to be
younger (mean age 25 vs. 27 years), have better educa-
tion and fewer children. Regarding baseline characteris-
tics, South African mothers had the highest body mass
index (BMI), and Ugandan mothers the highest number
of children (Table 1).
Breastfeeding was initiated within 1 h and on the first
day postpartum by 57.7% and 93.9% of mothers, respect-
ively (Table 2), and 99% had started any breastfeeding
within the first week (Table 3). The main reason for de-
layed initiation of breastfeeding was reported as a lack of
breast milk. EBF, PBF and MF were practiced by 95.9, 1.6
and 1.5%, respectively, in the first week (Table 3). Water-
based liquids were the most common prelacteal items
(6.2% of the participants) during this week (Table 4).
The median duration of any breastfeeding was
40.6 weeks (interquartile range (IQR; 32.3; 45.4; Table 5).
Burkina Faso had the longest median duration and
South Africa the shortest. The median duration of EBF
was 20.9 (IQR: 19.1; 21.1) weeks. PBF was reported only
during 59 monthly visits (4/1000 person-year). When
PBF was combined with EBF, the overall median dur-
ation remained the same (20.9; IQR: 19.7; 21.1).
At week 22, EPBF was practiced by 90.7, 48.8, 79.6 and
83.1% in Burkina Faso, South Africa, Uganda and Zambia,
respectively (Fig. 2 and Additional file 1). Nevertheless at
week 22 there was no significant difference between the
trial arms (p = 0.05, log rank test; in the lopinavir/ritonavir
arm, 70.3% practiced EBF vs. 69.1% in the lamivudine arm).
At week 50, 11.8, 4.7, 2.5 and 3.2% of the mothers
were continuing to breastfeed in Burkina Faso, South
Africa, Uganda and Zambia, respectively (Fig. 3).
The details of the food items that the infants received
are set out in detail in Table 4 (first week) and in the
Additional files 2, 3 (first year). There were major coun-
try differences in prelacteal feeds (Table 4). In the first
3 days of life, water-based items (including water, water
and sugar or glucose, water and salt, cow’s milk, infant
formula and traditional beverages) were given to 24,
12.5, 4.7 and 1% of the children in Burkina Faso,
Uganda, South Africa and Zambia, respectively. After
the first week of life (Additional file 2, 3), milk items
were mainly used in South Africa, Uganda and Zambia.
Porridge or cereals were were introduced at week 10 and
18 in Zambia and Uganda, respectively while in Burkina
Faso they were used from week 26. Soup, meat, fish or
egg were introduced as early as week 18 in South Africa,
Uganda and Zambia while these items were first seen in
infant’s food only at week 26 (0.5% for meat, fish or egg)
in Burkina Faso (additional file 2c). After cessation of
breastfeeding, 62 (5.1%) of 1225 mothers (25 (11.7%), 20
(7.3%) and 17 (3.2%) in South Africa, Zambia and
Uganda, respectively) resumed breastfeeding. In total, 54
(4.4%) mothers resumed breastfeeding once and stopped
breastfeeding permanently, and 8 (0.6%) resumed it
twice. The mean duration of all periods with resumed
breastfeeding was 17.2 days, and in calculating this mean,
we disregarded 5 women who had resumed breastfeeding
of long duration (mean duration of 108.2 days) and were
characterized as outliers. The mean duration of these
periods with resumed breastfeeding for mothers who
resumed once was 18.2 days (i.e. without these 5 women),
14.9 and 13.2 days for the first and second period,
respectively, for those who resumed twice. We did not
find any difference between the women who stopped
breastfeeding earlier (before 26 weeks) and resumed it
and those who stopped it later (after 26 weeks).
Risk factors analysis
Almost all the Burkina Faso mothers continued EPBF be-
yond 22 weeks after birth. We therefore removed them
from the pooled multivariable analysis on risk factors for
stopping EPBF (Additional file 2: Table S6). The groups of
mothers significantly more at risk to stop EPBF before
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Fig. 1 Study flow-chart
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26 weeks in the remaining 3 countries were the 25-30
year-old married, employed, and multiparous mothers, or
those in the lopinavir/ritonavir arm. On the other hand,
Ugandan and Zambian women were more likely to con-
tinue EPBF until 26 weeks than South African women.
The behaviour of South African women to stop EPBF
early affected the overall analysis, showing that the lopina-
vir/ritonavir arm was a risk factor in this situation.
With regard to any breastfeeding, Burkina Faso was
once again dropped from the multivariate analysis of the
determinants. The survival curve (Fig. 3) of any breast-
feeding by country shows a dramatic drop of the South
African curve from the beginning until around week 40.
From week 40, the remaining South African mothers
tended to breastfeed longer than those mothers in the
other countries. Having completed secondary school or
beyond was an independent risk factor for early cessa-
tion of any breastfeeding (Additional file 2: Table S6).
In the country-specific analyses (Additional file 2:
Table S7a), there were in general no large differences in
the infant feeding behavior, except for South Africa
where there was an interaction with trial allocation.
Children in the lopinavir/ritonavir group were 3 times
more likely to stop EPBF early than children from the
lamivudine group. In Uganda and Zambia, the trial drug
had no significant influence on infant feeding behavior.
Table 1 Study participants’ baseline characteristics
Burkina Faso South Africa Uganda Zambia All sites
N = 204 N = 213 N = 274 N = 534 N = 1225
n (%) n (%) n (%) n (%) n (%)
Age group
<25 years 54 (26.5) 73 (34.3) 107 (39.0) 200 (37.8) 434 (35.6)
25 – 30 years 75 (36.8) 67 (31.5) 97 (36.1) 175 (33.1) 414 (34.1)
30 and above 75 (36.8) 73 (34.3) 68 (24.8) 154 (29.0) 370 (30.3)
Literacy rate 103 (50.5) 211 (99.1) 261 (95.3) 487 (91.2) 1062 (86.7)
Education level (%)
Primary school 155 (76.0) 19 (0.5) 176 (15.7) 249 (18.7) 599 (13.0)
Secondary school and higher 49 (24.0) 194 (91.1) 98 (35.7) 285 (53.4) 626 (51.1)
Occupation: employed 18 (8.8) 89 (41.8) 97 (35.4) 92 (17.2) 296 (24.2)
Married/co-habiting 185 (90.7) 83 (38.0) 225 (82.1) 473 (88.6) 966 (78.9)
Primiparous 44 (21.6) 71 (33.3) 49 (17.9) 112 (21.0) 276 (22.5)
Surgical breast history 8 (3.9) 1 (0.5) 8 (2.9) 1 (0.2) 18 (1.5)
Mother’s HIV stage 1 190 (93.1) 210 (98.6) 253 (92.3) 533 (99.8) 1184 (96.6)
Facility delivery 200 (98.0) 211 (99.1) 212 (77.4) 518 (97.0) 1141 (93.1)
Vaginal delivery 191 (93.6) 139 (65.3) 256 (93.4) 514 (96.2) 1100 (89.8)
Female infant 86 (42.2) 105 (49.3) 144 (52.5) 259 (48.5) 594 (48.5)
Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI)
Mean BMI 23.8 (23.2; 24.3) 28.3 (27.5; 29.0) 23.0 (22.6; 23.4) 24.1 (23.7; 24.4) 24.5 (24.3; 24.8)
Mean number of children 2.8 (2.6; 3.0) 2.0 (1.9; 2.2) 3.5 (3.3; 3.7) 2.6 (2.5; 2.7) 2.7 (2.7; 2.8)
Table 2 Time to initiation of breastfeeding after birth
Hours Burkina Faso South Africa Uganda Zambia All sites
N = 204 N = 213 N = 274 N = 534 N = 1225
n (%) n (%) n (%) n (%) n (%)
0-1 14 (6.9) 109 (51.2) 152 (55.5) 432 (80.9) 707 (57.7)
2-5 73 (35.8) 85 (39.9) 76 (27.7) 74 (13.9) 308 (25.1)
6-12 54 (26.5) 10 (4.7) 32 (11.7) 22 (4.1) 118 (9.6)
12-24 4 (2.0) 3 (1.4) 6 (2.2) 4 (0.7) 17 (1.4)
Total initiated 1st day 145 (71.1) 207 (97.2) 266 (97.1) 532 (99.6) 1150 (93.9)
Somé et al. International Breastfeeding Journal  (2017) 12:22 Page 6 of 12
Contrary to any breastfeeding, having a secondary
school or higher education level was beneficial for EPBF
practice, allowing up to 40, 60 and 40 of babies to bene-
fit from EPBF in South Africa, Uganda and Zambia, re-
spectively. However, this association was significant only
for Zambian children. Being married or living as a
couple was a risk factor for shorter EPBF, with a signifi-
cant adjusted hazard ratio (AHR) of 1.6 (95% CI: 1.2;
2.1) and 2.6 (95% CI: 1.9; 3.6) in South Africa and
Zambia, respectively. A similar pattern was observed
with employed mothers and multiparous mothers. Late
initiation of breastfeeding (after 1 h) was associated with
shorter EPBF in Uganda and Zambia.
Discussion
In general, the mothers in this trial adhered to the breast-
feeding recommendations: 58% initiated breastfeeding
within the first hour and 94% within the first day. EPBF
was practiced at a high rate in all countries throughout
the 22-week period. This performance can probably be
Table 3 Feeding pattern during the first week of life by country
Breast feeding pattern Burkina Faso South Africa Uganda Zambia All sites
N = 204 N = 213 N = 274 N = 534 N = 1225
n (%) n (%) n (%) n (%) n (%)
Any breastfeeding first 3 days 200 (98.0) 206 (96.7) 272 (99.3) 532 (99.6) 1210 (98.8)
Any breastfeeding day 4-7 202 (99.0) 205(96.2) 273 (99.6) 533 (99.8) 1213 (99.0)
Exclusive breastfeeding throughout first 3 days 156 (76.5) 199 (93.4) 250 (91.2) 528 (98.9) 1133 (92.5)
Exclusive breastfeeding throughout days 4-7 177 (86.8) 200 (93.9) 266 (97.1) 532 (99.6) 1175 (95.9)
Predominant breastfeeding throughout first 3 days 34 (16.7) 2 (0.9) 18 (6.6) 1 (0.2) 55 (4.5)
Predominant breastfeeding throughout days 4-7 15 (7.3) 4 (1.9) 1 (0.4) 0 (0.0) 20 (1.6)
Mixed feeding first 3 days 10 (4.9) 5 (2.3) 4 (1.5) 3 (0.6) 22 (1.8)
Mixed feeding day 4-7 10 (4.9) 1 (0.5) 6 (2.2) 1 (0.2) 18 (1.5)
Table 4 Proportion of infants receiving different food items during the first week of life by country
Nutrient or other intake Burkina Faso South Africa Uganda Zambia All sites
N = 204 N = 213 N = 274 N = 534 N = 1225
n (%) n (%) n (%) n (%) n (%)
Days 1 to 3
Breast milk 200 (98.0) 206 (96.7) 272 (99.3) 532 (99.6) 1210 (98.8)
Water 34 (16.7) 5 (2.3) 12 (4.4) 0 (0.0) 51 (4.2)
Water + sugar or glucose 6 (2.9) 0 (0.0) 15 (5.5) 0 (0.0) 21 (1.7)
Water + salt 0 (0.0) 0 (0.0) 4 (1.5) 0 (0.0) 4 (0.3)
Juice 1 (0.5) 0 (0.0) 0 (0.0) 1 (0.2) 2 (0.2)
Cow’s milk 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 1 (0.1)
Infant formula 2 (1.0) 4 (1.9) 0 (0.0) 3 (0.6) 9 (0.7)
Liquid as part of traditional practice 6 (2.9) 1 (0.5) 3 (1.1) 0 (0.0) 10 (0.8)
Other 2 (1.0) 0 (0.0) 2 (0.4) 0 (0.0) 3 (0.2)
Days 4 to 7
Breast milk 20 2(99.0) 205 (96.2) 273 (99.6) 533 (99.8) 1213 (99.0)
Water 19 (9.3) 4 (1.9) 1 (0.4) 0(0.0) 24 (2.0)
Water + sugar or glucose 1 (0.5) 1 (0.5) 1 (0.4) 0 (0.0) 3 (0.2)
Tea 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1)
Juice 3 (1.5) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.2)
Infant formula 1 (0.5) 0 (0.0) 1 (0.4) 1 (0.2) 3 (0.2)
Powdered milk 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.1)
Liquid as part of traditional practice 6 (2.9) 1 (0.5) 3 (1.1) 0 (0.0) 10 (0.8)
Other 3 (1.5) 0 (0.0) 1 (0.4) 0 (0.0) 4 (0.3)
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attributed to the study design, including close tracking
of the mothers during the antenatal period and fre-
quent follow-up visits with infant feeding counselling.
The median durations of any and exclusive breastfeed-
ing were 40.6 and 20.9 weeks, respectively. At week 22,
>75% of the children were on EPBF. Only 4.7% were
breastfed at week 50.
In other recent studies of both the general population
and mothers living with HIV, findings showed that the
proportion of women initiating breastfeeding within the
first hour postpartum was between less than half and
76% [18, 38–40]. However, with respect to our study, the
country having the lowest percentage of women initiat-
ing breastfeeding within the first hour was Burkina Faso
(only 6.9%).
Under 10% of the participants in this trial gave pre-
lacteal feeds compared to 22 to 57% in other studies
[18, 20, 39, 40]. Burkina Faso had the highest propor-
tion of women giving prelacteal feeds (>16%). The same
feeding patterns were found in the PROMISE-EBF
study in Burkina Faso site with <4 and 11% of partici-
pants initiating breastfeeding within the first hour and
giving prelacteal feeding, respectively [41]. In Burkina
Faso, however, women breastfed longer compared to
the other countries, for which we have no clear explan-
ation. Our hypotheses are that the tradition through a
cultural influence, better counselling sessions and a
poorer economic context that could be accompanied
with difficulties in affording quality complementary
food for children, may have been important factors.
More mothers in South Africa (and to some extent in
Zambia) had to resume formal work after a few months,
preventing them from continuing breastfeeding.
In the Kesho Bora study [42], the participants from
Burkina Faso had a considerably lower level of educa-
tion, than in our study. In contrast to our study, South
Africa had the longest median duration of any breast-
feeding compared with Burkina Faso and Kenya. The
proportion of women initiating breastfeeding in the first
week and the median duration of any breastfeeding were
higher in our study (99% and 41 weeks vs. 70% and
20 weeks, respectively). Likewise, the Kesho Bora study
had a lower proportion of EBF (22% at 5 months) com-
pared to our study (75.3% at 5 months). Even comparing
the countries that participated in both the Kesho Bora
and our trial (Burkina Faso and South Africa), the exclu-
sive breastfeeding rate was higher in our study. In other
EBF studies with contexts similar to this trial, the
Table 5 Median duration of “any breastfeeding”, “exclusive breastfeeding” and “exclusive and predominant breastfeeding” in weeks
Feeding patterns Burkina Faso South Africa Uganda Zambia All sites
N = 204 N = 213 N = 274 N = 534 N = 1225
Median (p25; p75) Median (p25; p75) Median (p25; p75) Median (p25; p75) Median (p25; p75)
Any breastfeeding 46.5 (45.0; 48.7) 29.1 (13.0; 46.3) 39.9 (34.1; 43.0) 39.0 (33.0; 43.6) 40.6 (32.3; 45.4)
Exclusive breastfeeding 20.7 (18.9; 21.3) 19.5 (12.4; 21.0) 20.9 (19.6; 21.0) 21.0 (20.4; 21.1) 20.9 (19.1; 21.1)
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Fig. 2 Kaplan-Meier survival curve by country for exclusive and predominant breastfeeding until week 26 post-partum
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median durations of EBF varied from 1.8 [43] to
5 months [38, 43, 44] and the proportion of EBF at
6 months ranged from zero percent to 84% [18, 20, 42,
43, 45, 46]. Therefore one has to acknowledge the high
variability of infant feeding practices in sub-Saharan Af-
rica among HIV-positive women. In general, the
ANRS12174 participants adhered to a large extent to the
WHO HIV and infant feeding recommendations. The
trial setup and the frequent counselling is the most likely
explanation for that; thus, it is possible that frequent
quality counselling is required for the promotion of the
safe infant feeding practices among HIV-1 positive
women.
Interestingly, the trial allocation was a factor associ-
ated with breastfeeding behaviour, but only in South
Africa where the lopinavir/ritonavir group had a 3 times
higher risk of shorter EPBF compared to the lamivudine
group. It is possible that the poor palatability of lopina-
vir/ritonavir influenced the South African participants to
stop EPBF earlier than recommended. Why this hap-
pened only in South Africa is unclear, but formula-
feeding is more common in South Africa, which may be
one explanation. It is also possible that, due to the bad
taste, women in South Africa mixed the drug with other
foods than milk, unlike women in Uganda and Zambia
where they mixed it with breastmilk.
Our findings together with the ANRS 12174 trial
results [34] demonstrated enough that breastfeeding
in HIV-1 infected women could be almost as safer as
in HIV-1 uninfected mothers for the infants, provided
it is practised according to the international recom-
mendations. However, it is currently commonly ac-
cepted to breastfeed babies born to HIV-1 infected
mothers while the peri-exposure prophylaxis is as-
sured by the mothers taking lifelong anti-retroviral
medicines (option B+). Nonetheless, the efficacy dem-
onstrated for the option A in our studies required
some reflections on how to combine all these options
for an improved PMTCT strategy as we know that
some HIV reservoirs (including in breastmilk) [32]
are not fully controlled by the mother’s HAART. In
the other hands, some mothers may not be able to
afford or to take HAART.
There are certain limitations to our study. In some
sites, including Burkina Faso, the nutritional counsellors
were also collecting feeding data; therefore, there was a
risk for the mothers to under-report non-recommended
practices while emphasizing the recommended ones.
However, the counsellors were senior staff with consid-
erable experience in research and knew the techniques
needed to probe participants to obtain accurate data.
Furthermore, the Burkina Faso participants had the
highest proportion of prelacteal feeding, delayed initi-
ation of breastfeeding, among other items, which sug-
gests that information bias was limited. Moreover, our
findings regarding prelacteal feeding practices and
breastfeeding initiation time in Burkina Faso are com-
parable with PROMISE-EBF findings [41], where peer
counsellors were not the same as the investigators who
collected the data.
Other potential limitations are the trial context with a
fixed time of 50 weeks for provision of the infant
prophylaxis, which limits the generalisability of our data
particularly on ‘any breastfeeding’, and the selection
criteria that may not allow any extrapolation of the re-
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Fig. 3 Kaplan-Meier survival curve by country for any breastfeeding until week 50 post-partum
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sample size, the long duration of our follow-up, the
international multicentre design, as well as the stringent
randomised clinical trial context and the cohort design,
added value and accuracy to our findings.
Conclusion
ANRS 12174 trial participants were relatively more
successful in practicing EPBF than has been seen in sev-
eral previous studies. However, in Burkina Faso, late initi-
ation of breastfeeding postpartum and the extensive use
of prelacteal feeds remain prevalent. Why women in the
lopinavir/ritonavir arm were more likely to stop EPBF in
South Africa is a question requiring further investigation.
There is a need to improve breastfeeding and complemen-
tary feeding practices of children, particularly those ex-
posed to HIV and anti-retrovirals, taking into account
context and socio-demographic factors.
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